Clinical trial
Image-guided Targeted Doxorubicin Delivery With Hyperthermia to Optimize Loco-regional Control in Breast Cancer
NCT03749850
Study timeline
Study start (estimated)2021-03-01Date precision: month
Registry last updated2021-02-17
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Metastatic Breast Cancerunresolved
Breast Cancerunresolved
Breast Neoplasmsunresolved
Stage IV Breast Cancerunresolved
Metastatic Cancerunresolved
Invasive Ductal Breast Cancerunresolved
Adenocarcinoma Breastunresolved
Interventions
LTLDDRUG
MR-HIFU induced hyperthermiaPROCEDURE
CyclophosphamideDRUG · verified · RxNorm: cyclophosphamide
Sponsors & collaborators
UMC Utrechtlead sponsor
Dutch Cancer Societycollaborator
Center for Translational Molecular Medicinecollaborator
Vrienden UMC Utrechtcollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03749850 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.